Summary
This prediction ended on 12.11.13 with a price of €4.36. With a performance of -5.85%, the SELL prediction for Evotec SE by mohabbatein was down slightly. mohabbatein has 50% into this predictionEvotec is a German-based biotech company that provides drug discovery and development solutions to pharmaceutical and biotechnology companies. The company operates in the fields of neuroscience, immunology, oncology, and infectious diseases, and its services include hit identification, target validation, and preclinical and clinical development. Evotec has partnerships with major pharmaceutical companies and has developed its own pipeline of drugs, with a focus on developing treatments for conditions such as Alzheimer's disease and diabetes. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of approximately €5.5 billion.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Evotec SE | -9.238% | -9.238% | -71.540% | -85.181% |
iShares Core DAX® | -0.372% | 5.236% | 16.908% | 16.016% |
iShares Nasdaq 100 | -1.950% | 1.680% | 19.890% | 31.832% |
iShares Nikkei 225® | -1.690% | 7.286% | 12.202% | 3.400% |
iShares S&P 500 | -0.399% | 2.379% | 20.975% | 36.224% |
Comments by mohabbatein for this prediction
In the thread Evotec AG diskutieren
Puh ist das heiß hier...
Die Nervosität bei den Aktionären scheint (endlich) langsam zu steigen. Gestern gabs schonmal knackige Verluste. Noch immer wird zwar jede neue Pressemitteilung kräftig gefeiert. Aber mich beschleicht zunehmend der Verdacht, dass die PR-Abteilung von Evotec auf einer gemeinsamen Push-Fortbildung war. Ich denke, irgendwann reicht es und man konzentriert sich wieder mehr auf die Fakten. Hier regiert derzeit die Gier. Wie lange noch?
SELL.